tradingkey.logo
tradingkey.logo
Search

Natera Inc

NTRA
Add to Watchlist
332.030USD
+7.190+2.21%
Close 08-21 16:00ET
47.65BMarket Cap
LossP/E TTM

Forecast

Currency: USD Updated: 2026-08-21
Previous score
8.58
Change
0
The current earnings forecast score of Natera Inc is 8.58, ranking 10 out of 72 in the Healthcare Providers & Services industry. The average price target is 239.00, with a high of 280.00 and a low of 186.00.

Analyst Rating

Based on 24 analysts
Buy
Current Rating
329.910
Target Price
+1.56%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

59
Total
9
Median
9
Average
Company name
Ratings
Analysts
Natera Inc
NTRA
24
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
25
Tenet Healthcare Corp
THC
23
Universal Health Services Inc
UHS
22
1
2
3
...
12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Natera Inc's expected revenue for the next quarter?

Natera Inc's expected revenue is 704.62M.

What is Natera Inc's price target?

Analysts forecast that Natera Inc's price target is USD 239.00, with the highest forecast at USD 280.00 and the lowest forecast at USD 186.00.

How have Natera IncNTRA's recent earnings per share performed?

The market expectation was USD -0.47, while Natera IncNTRA's earnings per share (EPS) for the previous quarter was USD -0.60. EPS for the next quarter is expected at USD -0.24.

What is the analyst rating for Natera Inc?

Based on the ratings of Natera Inc's stock from 24 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.